Stage IIB Prostate Cancer Terminated Phase 2 Trials for Green tea leaf (DB14307)

IndicationStatusPhase
DBCOND0028879 (Stage IIB Prostate Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01928485Green Tea Extract in Treating Patients With Low-Risk Prostate CancerTreatment